These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 12573364

  • 1. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
    Tselepis AD, John Chapman M.
    Atheroscler Suppl; 2002 Dec; 3(4):57-68. PubMed ID: 12573364
    [Abstract] [Full Text] [Related]

  • 2. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase.
    Castro Faria Neto HC, Stafforini DM, Prescott SM, Zimmerman GA.
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():83-91. PubMed ID: 15962103
    [Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
    Min JH, Wilder C, Aoki J, Arai H, Inoue K, Paul L, Gelb MH.
    Biochemistry; 2001 Apr 17; 40(15):4539-49. PubMed ID: 11294621
    [Abstract] [Full Text] [Related]

  • 4. The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2.
    Gora S, Lambeau G, Bollinger JG, Gelb M, Ninio E, Karabina SA.
    Biochim Biophys Acta; 2006 Sep 17; 1761(9):1093-9. PubMed ID: 16962371
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 17; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 7. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E.
    Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095
    [Abstract] [Full Text] [Related]

  • 8. Extracellular phospholipases in atherosclerosis.
    Karabina SA, Gora S, Atout R, Ninio E.
    Biochimie; 2010 Jun 15; 92(6):594-600. PubMed ID: 20153800
    [Abstract] [Full Text] [Related]

  • 9. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
    Eisaf M, Tselepis AD.
    Biochem Pharmacol; 2003 Dec 01; 66(11):2069-73. PubMed ID: 14609731
    [Abstract] [Full Text] [Related]

  • 10. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C, Sigari F, Segrado T, Hörkkö S, Hama S, Subbaiah PV, Miwa M, Navab M, Witztum JL, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1999 Jun 01; 19(6):1437-46. PubMed ID: 10364074
    [Abstract] [Full Text] [Related]

  • 11. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G, Zaręba M, Warpas A, Jamroz-Wiśniewska A, Rusek M, Czechowska G, Bełtowski J.
    Eur J Pharmacol; 2019 May 05; 850():180-189. PubMed ID: 30768981
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R, De Geest B, Stengel D, Mertens A, Lox M, Theilmeier G, Michiels C, Raes M, Bult H, Collen D, Van Veldhoven P, Ninio E, Holvoet P.
    Circulation; 2001 May 22; 103(20):2495-500. PubMed ID: 11369691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
    Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM.
    J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC, Tselepis AD.
    Biochim Biophys Acta; 2009 May 05; 1791(5):327-38. PubMed ID: 19272461
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study.
    Winkler K, Winkelmann BR, Scharnagl H, Hoffmann MM, Grawitz AB, Nauck M, Böhm BO, März W.
    Circulation; 2005 Mar 01; 111(8):980-7. PubMed ID: 15710755
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
    Häkkinen T, Luoma JS, Hiltunen MO, Macphee CH, Milliner KJ, Patel L, Rice SQ, Tew DG, Karkola K, Ylä-Herttuala S.
    Arterioscler Thromb Vasc Biol; 1999 Dec 01; 19(12):2909-17. PubMed ID: 10591668
    [Abstract] [Full Text] [Related]

  • 20. To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.
    Marathe GK, Pandit C, Lakshmikanth CL, Chaithra VH, Jacob SP, D'Souza CJ.
    J Lipid Res; 2014 Sep 01; 55(9):1847-54. PubMed ID: 24859738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.